Contra-indicated in patients with severe bone marrow depression, hepatic or renal impairment.
Not available in the USA.
- TRADE NAMES: S-1; Teysuno (Taiho Pharma)
- INDICATIONS: Gastric, colorectal, head and neck cancers, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer
- SYNONYM: TS-1; S-1
- CLASS: Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor)
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Capecitabine, Flucytosine, Fluorouracil, Other fluoropyrimidine-group antineoplastics, Phenytoin, Uracil/Tegafur, Warfarin - PREGNANCY: Contra-indicated in pregnancy
- See adverse reactions attributed to class:
Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor)
Please login to view the rest of this drug profile.
Page last updated 08/07/2024
